-
Multiple_Malignancy_Familial_Comparison
Study
EGAS00001000333
-
Rapid identification of somatic genome rearrangements as personalized biomarkers for blood-based cancer monitoring
Study
EGAS00001003963
-
Multifocal cohort analysis unveils cell types associated with regional lymph node seeding in prostate cancer
Study
EGAS00001006715
-
Impact of mutational profiles on response of primary oestrogen receptor-positive breast cancers to oestrogen deprivation
Study
EGAS00001001940
-
Integrative_Oncogenomics_of_Multiple_Myeloma
Study
EGAS00001000036
-
Reconstruction of complex rearrangement patterns causing the initiation of clear cell renal cell carcinoma.
Study
EGAS00001004015
-
RNA sequencing and Illumina 2.5M SNP array data collected from 675 commonly used human cancer cell lines.
Study
EGAS00001000610
-
Exome_sequencing_of_EBV_driven_lymphoma
Study
EGAS00001001021
-
Combination pembrolizumab and radiotherapy induces systemic anti-tumor immune responses in immunologically-cold non-small cell lung cancer
Study
EGAS50000000277
-
ACUITI
Study
EGAS50000000962
-
Whole exome sequencing of advanced gastric cancer
Study
EGAS00001004086
-
Concurrent germline and somatic pathogenic BAP1 variants in a patient with metastatic bladder cancer
Study
EGAS00001004055
-
Myeloid cell networks govern re-establishment of original immune landscapes in recurrent ovarian cancer
Study
EGAS50000001069
-
Distinct genomic profiles and clinical outcomes in constitutional mismatch repair deficiency-associated high-grade gliomas: insights into mutational signatures and clonal evolution
Study
EGAS50000001506
-
Genomic Data from Patients with Advanced Rare Cancers Treated with Pembrolizumab
Study
EGAS50000001508
-
IMMUcan Upstream SCCHN3 cohort
Study
EGAS50000001505
-
Colorectal_organoids_and_tumoroids___pulldown
Study
EGAS00001000869
-
Comparison of structural variations from 10X Genomics linked-reads and conventional Illumina short-reads sequencing
Study
EGAS00001004093
-
Transcriptomic Data from Patients with Advanced Rare Cancers Treated with Pembrolizumab
Study
EGAS50000001509
-
Organoid_Derivation_Pilot__RNAseq
Study
EGAS00001002223
-
Molecular investigation of BCC HHI-ICI combination therapy
Study
EGAS50000001481
-
SDH_deficient_renal_tumours___RNA_
Study
EGAS00001004103
-
Rare disruptive mutations in ciliary function genes contribute to testicular cancer susceptibility
Study
EGAS00001001789
-
Matched_Pair_Cancer_Cell_line_Whole_Genomes
Study
EGAS00001000160
-
Spatiotemporal evolution and inter-patient heterogeneity in primary and recurrent/metastatic head and neck squamous cell carcinoma
Study
EGAS00001007464
-
Comparison of 133/144bp dominant phenotype vs 166bp dominant phenotype.
Study
EGAS00001004135
-
Targeted sequencing of breast cancers with germline BRCA1/2 mutations
Study
EGAS00001004182
-
Metastatic Adult Pancreatoblastoma: Multimodal Treatment and Molecular Characterization of a Very Rare Disease (NCT MASTER)
Study
EGAS00001004157
-
Neoadjuvant immunotherapy leads to pathological responses in MMR proficient and MMR deficient early stage colon cancers
Study
EGAS00001004160
-
cfRRBS on cfDNA from pediatric cancer
Study
EGAS00001004194
-
Targeted next-generation sequencing of 13 chordoid gliomas of the third ventricle
Study
EGAS00001002733
-
Integration of genomics and histology reveals diagnosis and effective therapy of refractory cancer of unknown primary with PDL1 amplification (H021)
Study
EGAS00001001846
-
Oncogenic gene fusions in primary colon cancers
Study
EGAS00001002197
-
pancreatic ductal adenocarcinoma exomes in study: Pro-immunogenic Impact of MEK inhibition combined with an anti-CD40 immunostimulatory antibody
Study
EGAS00001004196
-
Heterogeneous Genomic Evolution and Immune Microenvironments in Metastatic Lung Cancer
Study
EGAS00001004228
-
PMF_Exome_Study
Study
EGAS00001000175
-
The Dynamic Immune Behavior of Primary and Metastatic Ovarian Carcinoma
Study
EGAS50000000038
-
Methylation data for Genomic landscapes of endometrioid and mucinous ovarian cancers and morphologically similar tumor types
Study
EGAS00001008175
-
Immunogenomics of colorectal cancer response to immune checkpoint blockade
Study
EGAS00001004438
-
Primary_Lung_Cancer_whole_genome_study
Study
EGAS00001000354
-
UROMOL 2020 - RNA-seq data
Study
EGAS00001004693
-
Clinical Implications of Genomic Alterations in the Tumor and Circulation of Pancreatic Cancer Patients
Study
EGAS00001001257
-
Evolutionary dynamics of residual disease in human glioblastoma
Study
EGAS00001003043
-
Exomes of High-risk Prostate cancer
Study
EGAS00001001015
-
Mesenchymal inflammation drives genotoxic stress in hematopoietic stem cells and predicts disease evolution in human pre-leukemia
Study
EGAS00001001926
-
CRC Promoter capture Hi-C
Study
EGAS00001001946
-
RNA-seq study of a Princess Margaret Cancer Centre human acute myeloid leukemia patient cohort
Study
EGAS00001004792
-
Search for new loci and low-frequency variants influencing glioma risk by exome-array analysis
Study
EGAS00001001258
-
Similarity and diversity of the tumor microenvironment in multiple metastases: critical implications for overall and progression-free survival of high-grade serous ovarian cancer.
Study
EGAS00001002065
-
Tracing the origin of disseminated tumor cells in breast cancer using single-cell sequencing
Study
EGAS00001002102
-
Spatial genomic heterogeneity in multiple myeloma revealed by multi- region sequencing
Study
EGAS00001002111
-
Inter and intra - tumor heterogeneity in Colorectal Cancer
Study
EGAS00001002150
-
Whole Exome Sequencing of Localized Prostate Cancer Patients
Study
EGAS00001005685
-
Angiosarcoma_RNA_sequencing
Study
EGAS00001000590
-
Preclinical_evolution_of_haematological_malignancies_
Study
EGAS00001002128
-
Scalable whole-genome single-cell library preparation without pre-amplification
Study
EGAS00001002170
-
Novel Epigenetic Markers for Toxicity after Intraoperative and Conventional Radiotherapy for Breast Cancer
Study
EGAS00001001279
-
RNA seq on 19 samples of Radiation-Induced Meningiomas
Study
EGAS00001002318
-
Mosaic_Colorectal_Metastasis
Study
EGAS00001000613
-
TMD_AMKL_targeted_follow_up
Study
EGAS00001000569
-
CancerLocator: Non-Invasive Cancer Diagnosis and Tissue-of-Origin Prediction Using Methylation Profiles of Cell-Free DNA
Study
EGAS00001002211
-
Clinical Cancer Genomic Profiling by Three-Platform Sequencing of Whole Genome, Whole Exome and Transcriptome
Study
EGAS00001002217
-
Molecular Classification of Lymph Node Metastases Subtypes Predict for Survival in Head and Neck Cancer
Study
EGAS00001003233
-
ExomeSeq Neoantigen Immunogenicity Landscapes
Study
EGAS00001007508
-
Divergence between high metastatic tumor burden and low circulating tumor DNA concentration in metastasized breast cancer
Study
EGAS00001000625
-
E-cadherin inactivation shapes tumor microenvironment specificities in invasive lobular carcinoma
Study
EGAS50000001760
-
Poly(A) RNA sequencing of hepatocellular carcinoma tumors and their matched noncancerous liver tissues
Study
EGAS00001002337
-
Patient-derived organoids as predictive models for drug testing and repurposing in glioblastoma therapy
Study
EGAS50000001221
-
Phenotypic characterization and prognostic impact of CD103+ tissue-resident memory T cells in diffuse large B cell lymphoma
Study
EGAS50000000943
-
Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes
Study
EGAS00001002390
-
The Genomic Landscape of Response to EGFR Blockade in Colorectal Cancer
Study
EGAS00001001305
-
Linked-Read Whole Genome Sequencing Profiles Structural Variant Landscape of Gliomas with Barcode-Level Evidence
Study
EGAS50000000947
-
Cisplatin increases sensitivity to FGFR inhibition in patient-derived xenograft models of lung squamous cell carcinoma
Study
EGAS00001002423
-
Genome-wide analyses of cell-free DNA for therapeutic monitoring of patients with pancreatic cancer
Study
EGAS50000000923
-
Recurrent epimutations activate gene body promoters in primary glioblastoma
Study
EGAS00001000685
-
Employing_single_cell_sequencing_for_detection_of_mutational_signatures_reflecting_on_going_mutagenesis_
Study
EGAS00001002679
-
Genetic alterations in metastatic uveal melanoma
Study
EGAS00001003303
-
Lung_Cancer_Whole_Genomes
Study
EGAS00001000148
-
Enhancer profiling identifies epigenetic markers of endocrine resistance and reveals therapeutic options for metastatic castration-resistant prostate cancer patients (LuCaP cell line data)
Study
EGAS50000000917
-
High Grade Serous Ovarian Carcinomas Originate in the Fallopian Tube
Study
EGAS00001002589
-
APOBEC3 mutagenesis drives therapy resistance in breast cancer
Study
EGAS50000000875
-
We performed whole-exome sequencing of 20 samples (10 actinic keratosis and 10 cutaneous squamous cell carcinoma) to investigate a potential relationship between DNA methylation-based subtypes and genetic mutation patterns (Rodriguez-Paredes et al., Nat Commun 2017)
Study
EGAS00001002670
-
Metastatic_Prostate_Follow_Up
Study
EGAS00001000730
-
Gut microbiome modulates response to anti PD1 immunotherapy in metastatic melanoma patients
Study
EGAS00001002698
-
Next-Generation Sequencing of RNA and DNA Isolated from Paired Fresh-Frozen and Formalin-Fixed Paraffin-Embedded Samples of Human Cancer and Normal Tissue
Study
EGAS00001000737
-
Expression profiles of DLL1 positive and negative subpopulations in metastatic colorectal cancer organoids under cetuximab treatment
Study
EGAS50000001780
-
Whole Exome Sequencing of Human Gastro-esophageal Cancer PDXs
Study
EGAS50000000966
-
Germline alterations of acute myeloid leukemia
Study
EGAS00001002760
-
Whole exome and transcriptome sequencing of biliary tract cancer
Study
EGAS00001000950
-
Drug screening and whole genome sequencing of primary cells and cell lines from ovarian cancer patients to associate genomic aberrations with in vitro drug sensitivities
Study
EGAS00001002239
-
MutWP6__CRUK_Grand_Challenge_Mutographs_of_Cancer__Botseq
Study
EGAS00001004330
-
Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment
Study
EGAS00001003886
-
EBV_AID_project
Study
EGAS00001000955
-
Genomic landscape of oral cancers (Illumina RNA-Seq)
Study
EGAS00001003237
-
Xenograft_Sequencing
Study
EGAS00001000140
-
Low T cell diversity is associated with poor outcome in bladder cancer - Total RNAseq data
Study
EGAS50000000939
-
Low T cell diversity is associated with poor outcome in bladder cancer - Single cell RNAseq and TCRseq data
Study
EGAS50000000938
-
Low T cell diversity is associated with poor outcome in bladder cancer - Bulk TCRseq data
Study
EGAS50000000940
-
Colorectal advanced adenomas NKI-AvL TGO COCOS series
Study
EGAS00001002952
-
Somatic_mutation_and_clonal_evolution_normal_breast_tissue_TGS
Study
EGAS00001002858